Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
Domain	JmjC	KDM5B JMJD4 KDM5D JMJD1C	5.31e-05	24	164	4	PF02373
Domain	RHD_dimer	NFATC1 NFATC3 NFKB2	7.62e-05	10	164	3	IPR032397
Domain	RHD_dimer	NFATC1 NFATC3 NFKB2	7.62e-05	10	164	3	PF16179
Domain	REL_1	NFATC1 NFATC3 NFKB2	7.62e-05	10	164	3	PS01204
Domain	-	NFATC1 NFATC3 NFKB2	7.62e-05	10	164	3	2.60.40.340
Domain	NFkB/Dor	NFATC1 NFATC3 NFKB2	7.62e-05	10	164	3	IPR000451
Domain	RHD_DNA_bind_dom	NFATC1 NFATC3 NFKB2	7.62e-05	10	164	3	IPR011539
Domain	RHD_DNA_bind	NFATC1 NFATC3 NFKB2	7.62e-05	10	164	3	PF00554
Domain	REL_2	NFATC1 NFATC3 NFKB2	7.62e-05	10	164	3	PS50254
Domain	PQQ_2	EMC1 AASDH	7.66e-05	2	164	2	PF13360
Domain	IPT	PKHD1L1 NFATC1 NFATC3 NFKB2	8.59e-05	27	164	4	SM00429
Domain	IPT	PKHD1L1 NFATC1 NFATC3 NFKB2	1.70e-04	32	164	4	IPR002909
Domain	JMJC	KDM5B JMJD4 KDM5D JMJD1C	1.70e-04	32	164	4	PS51184
Domain	JmjC_dom	KDM5B JMJD4 KDM5D JMJD1C	1.70e-04	32	164	4	IPR003347
Domain	JmjC	KDM5B JMJD4 KDM5D JMJD1C	1.92e-04	33	164	4	SM00558
Domain	Ig_E-set	ARRDC1 PKHD1L1 AREL1 NFATC1 NFATC3 NFKB2	3.12e-04	104	164	6	IPR014756
Domain	Lys_sp_deMease-like_dom	KDM5B KDM5D	4.55e-04	4	164	2	IPR013637
Domain	FAM47	FAM47C FAM47B	4.55e-04	4	164	2	PF14642
Domain	PLU-1	KDM5B KDM5D	4.55e-04	4	164	2	PF08429
Domain	TF_AF4/FMR2	AFF3 AFF1	4.55e-04	4	164	2	IPR007797
Domain	FAM47	FAM47C FAM47B	4.55e-04	4	164	2	IPR032743
Domain	AF-4	AFF3 AFF1	4.55e-04	4	164	2	PF05110
Domain	Protocadherin	PCDH11Y PCDH11X	7.53e-04	5	164	2	PF08374
Domain	zf-C5HC2	KDM5B KDM5D	7.53e-04	5	164	2	PF02928
Domain	NFAT	NFATC1 NFATC3	7.53e-04	5	164	2	IPR008366
Domain	Znf_C5HC2	KDM5B KDM5D	7.53e-04	5	164	2	IPR004198
Domain	Protocadherin	PCDH11Y PCDH11X	7.53e-04	5	164	2	IPR013585
Domain	DCX	DCLK2 DCLK1	1.12e-03	6	164	2	SM00537
Domain	PQQ_repeat	EMC1 AASDH	1.12e-03	6	164	2	IPR002372
Domain	-	EMC1 AASDH	1.12e-03	6	164	2	2.140.10.10
Domain	Quinoprotein_ADH-like_fam	EMC1 AASDH	1.12e-03	6	164	2	IPR027295
Domain	p53-like_TF_DNA-bd	TBX18 NFATC1 NFATC3 NFKB2	1.20e-03	53	164	4	IPR008967
Domain	-	DCLK2 DCLK1	1.56e-03	7	164	2	3.10.20.230
Domain	DCX	DCLK2 DCLK1	1.56e-03	7	164	2	PF03607
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	SEMA6B ZNF48 POLR2A NLRX1 AKNA SMG5 TEP1 NPHP4 RYR1 FANCA CNPPD1 HIVEP3 MROH1 MROH6 NFATC1 BTBD7 UCKL1 NFKB2 TMEM132A SEC16A FLCN IQCE	2.11e-08	1105	168	22	35748872
Pubmed	Extracellular HIV-Tat induces cyclooxygenase-2 in glial cells through activation of nuclear factor of activated T cells.	PTGS2 NFATC1 NFATC3	3.82e-06	7	168	3	18097055
Pubmed	Resolution of cell fate decisions revealed by single-cell gene expression analysis from zygote to blastocyst.	KDM5B ZNF48 LIMD1 SERTAD2 JMJD4 ZNF202 KDM5D PKHD1L1 HIVEP3 GFI1B NFATC1 BTBD7 NFKB2 POU2F3 MYB	9.79e-06	808	168	15	20412781
Pubmed	Prediction of the coding sequences of unidentified human genes. VII. The complete sequences of 100 new cDNA clones from brain which can code for large proteins in vitro.	N4BP3 AREL1 SEC16A IGSF1 GARRE1 DCLK1	1.19e-05	104	168	6	9205841
Pubmed	Detection of targeted GFP-Hox gene fusions during mouse embryogenesis.	HOXA1 HOXC13	2.32e-05	2	168	2	9789037
Pubmed	High extracellular calcium-induced NFATc3 regulates the expression of receptor activator of NF-κB ligand in osteoblasts.	NFATC1 NFATC3	2.32e-05	2	168	2	21514407
Pubmed	Conservation of PCDHX in mammals; expression of human X/Y genes predominantly in brain.	PCDH11Y PCDH11X	2.32e-05	2	168	2	11003707
Pubmed	Cell-specific expression of ENACα gene by FOXA1 in the glucocorticoid receptor pathway.	FOXA1 SCNN1A	2.32e-05	2	168	2	32838581
Pubmed	Control of bone resorption in mice by Schnurri-3.	HIVEP3 NFATC1	2.32e-05	2	168	2	22573816
Pubmed	Fast-evolving cofactors regulate the role of HEATR5 complexes in intra-Golgi trafficking.	HEATR5A HEATR5B	2.32e-05	2	168	2	38240799
Pubmed	Pcdh11x Negatively Regulates Dendritic Branching.	PCDH11Y PCDH11X	2.32e-05	2	168	2	25687328
Pubmed	Association of AFF1 rs340630 and AFF3 rs10865035 polymorphisms with systemic lupus erythematosus in a Chinese population.	AFF3 AFF1	2.32e-05	2	168	2	22983539
Pubmed	Cadherin expression delineates the divisions of the postnatal and adult mouse amygdala.	PCDH11Y PCDH11X	2.32e-05	2	168	2	22592879
Pubmed	Protocadherin X ( PCDHX) and Y ( PCDHY) genes; multiple mRNA isoforms encoding variant signal peptides and cytoplasmic domains.	PCDH11Y PCDH11X	2.32e-05	2	168	2	14727141
Pubmed	Lack of association between protocadherin 11-X/Y (PCDH11X and PCDH11Y) polymorphisms and late onset Alzheimer's disease.	PCDH11Y PCDH11X	2.32e-05	2	168	2	21276771
Pubmed	NFATc1 activation promotes the invasion of U251 human glioblastoma multiforme cells through COX-2.	PTGS2 NFATC1	2.32e-05	2	168	2	25738651
Pubmed	Deletion of Protein Tyrosine Phosphatase 1B (PTP1B) Enhances Endothelial Cyclooxygenase 2 Expression and Protects Mice from Type 1 Diabetes-Induced Endothelial Dysfunction.	PTGS2 PTPN1	2.32e-05	2	168	2	25974252
Pubmed	DKK3 promotes oxidative stress injury and fibrosis in HK-2 cells by activating NOX4 via β-catenin/TCF4 signaling.	NOX4 DKK3	2.32e-05	2	168	2	37368156
Pubmed	Accelerated evolution of Protocadherin11X/Y: a candidate gene-pair for cerebral asymmetry and language.	PCDH11Y PCDH11X	2.32e-05	2	168	2	16874762
Pubmed	PCDH11 is X/Y homologous in Homo sapiens but not in Gorilla gorilla and Pan troglodytes.	PCDH11Y PCDH11X	2.32e-05	2	168	2	16825765
Pubmed	Doublecortin-like kinase enhances dendritic remodelling and negatively regulates synapse maturation.	DCLK2 DCLK1	2.32e-05	2	168	2	23385585
Pubmed	The protocadherin 11X/Y (PCDH11X/Y) gene pair as determinant of cerebral asymmetry in modern Homo sapiens.	PCDH11Y PCDH11X	2.32e-05	2	168	2	23600975
Pubmed	A comparative analysis of the pig, mouse, and human PCDHX genes.	PCDH11Y PCDH11X	2.32e-05	2	168	2	15112107
Pubmed	Dendritic cell-specific ablation of the protein tyrosine phosphatase Shp1 promotes Th1 cell differentiation and induces autoimmunity.	ITGAX PTPN6	2.32e-05	2	168	2	22539788
Pubmed	Protocadherin 11X/Y a human-specific gene pair: an immunohistochemical survey of fetal and adult brains.	PCDH11Y PCDH11X	2.32e-05	2	168	2	22744706
Pubmed	Reciprocal regulation of NADPH oxidases and the cyclooxygenase-2 pathway.	NOX4 PTGS2	2.32e-05	2	168	2	21907277
Pubmed	Temporal dissection of an enhancer cluster reveals distinct temporal and functional contributions of individual elements.	POLR2A FGF5	2.32e-05	2	168	2	33482114
Pubmed	Quantitative analysis of alternative transcripts of human PCDH11X/Y genes.	PCDH11Y PCDH11X	2.32e-05	2	168	2	19859901
Pubmed	NFAT2 regulates COX-2 expression and modulates the integrin repertoire in endothelial cells at the crossroads of angiogenesis and inflammation.	PTGS2 NFATC1	2.32e-05	2	168	2	24657343
Pubmed	Genetic polymorphisms of cell adhesion molecules in Behcet's disease in a Chinese Han population.	ITGAX CD6	2.32e-05	2	168	2	27108704
Pubmed	Methylmercury promotes prostacyclin release from cultured human brain microvascular endothelial cells via induction of cyclooxygenase-2 through activation of the EGFR-p38 MAPK pathway by inhibiting protein tyrosine phosphatase 1B activity.	PTGS2 PTPN1	2.32e-05	2	168	2	28958600
Pubmed	Sex differences in structure and expression of the sex chromosome genes CHD1Z and CHD1W in zebra finches.	PCDH11Y KDM5D PCDH11X	3.06e-05	13	168	3	14660691
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	DDX31 AASDH CCDC88A NFATC1 UBR5 NFATC3 NFKB2 SEC16A PATJ ANKRD52 GARRE1 NIN	3.16e-05	588	168	12	38580884
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	CRIM1 TTLL5 NPHP4 JMJD1C UBR5 SEC16A PALLD	3.34e-05	184	168	7	32908313
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ESPN LIMD1 STXBP5L PCDH11Y AFF3 PRR5 TEP1 ADCY1 JMJD1C HIVEP3 SENP1 NFATC1 UCKL1 LMLN SCNN1A AFF1 DCLK2 PATJ ZMAT1 FAM149A	3.66e-05	1489	168	20	28611215
Pubmed	NFAT transcription factors are essential and redundant actors for leukemia initiating potential in T-cell acute lymphoblastic leukemia.	NFATC1 NFATC3	6.94e-05	3	168	2	34234374
Pubmed	MYB regulates the SUMO protease SENP1 and its novel interaction partner UXT, modulating MYB target genes and the SUMO landscape.	SENP1 MYB	6.94e-05	3	168	2	37468105
Pubmed	Regulation of Cyclooxygenase-2 Expression in Human T Cells by Glucocorticoid Receptor-Mediated Transrepression of Nuclear Factor of Activated T Cells.	PTGS2 NFATC1	6.94e-05	3	168	2	36362060
Pubmed	Monitoring phosphatase reactions of multiple phosphorylated substrates by reversed-phase HPLC.	PTPN1 PTPN6	6.94e-05	3	168	2	17416557
Pubmed	Specific and redundant roles for NFAT transcription factors in the expression of mast cell-derived cytokines.	NFATC1 NFATC3	6.94e-05	3	168	2	17082579
Pubmed	Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2.	PTGS2 NFATC1	6.94e-05	3	168	2	15632146
Pubmed	Molecular assembly of CD46 with CD9, alpha3-beta1 integrin and protein tyrosine phosphatase SHP-1 in human macrophages through differentiation by GM-CSF.	CD46 PTPN6	6.94e-05	3	168	2	11858824
Pubmed	Molecular cloning and functional characterization of murine cDNA encoding transcription factor NFATc.	NFATC1 NFATC3	6.94e-05	3	168	2	9388475
Pubmed	Cadherin expression in the somatosensory cortex: evidence for a combinatorial molecular code at the single-cell level.	PCDH11Y PCDH11X	6.94e-05	3	168	2	21129452
Pubmed	Limited Regeneration Potential with Minimal Epicardial Progenitor Conversions in the Neonatal Mouse Heart after Injury.	TBX18 NFATC1	6.94e-05	3	168	2	31269439
Pubmed	Hypoxia Triggers SENP1 (Sentrin-Specific Protease 1) Modulation of KLF15 (Kruppel-Like Factor 15) and Transcriptional Regulation of Arg2 (Arginase 2) in Pulmonary Endothelium.	ARG2 SENP1	6.94e-05	3	168	2	29472234
Pubmed	DCLK1 promotes colorectal cancer stemness and aggressiveness via the XRCC5/COX2 axis.	PTGS2 DCLK1	6.94e-05	3	168	2	35910805
Pubmed	The protein tyrosine phosphatase PTP1B is a negative regulator of CD40 and BAFF-R signaling and controls B cell autoimmunity.	PTPN1 PTPN6	6.94e-05	3	168	2	24590766
Pubmed	NFATc3, a lymphoid-specific NFATc family member that is calcium-regulated and exhibits distinct DNA binding specificity.	NFATC1 NFATC3	6.94e-05	3	168	2	7650004
Pubmed	Nox4 redox regulation of PTP1B contributes to the proliferation and migration of glioblastoma cells by modulating tyrosine phosphorylation of coronin-1C.	NOX4 PTPN1	6.94e-05	3	168	2	24239742
Pubmed	DUSP28 links regulation of Mucin 5B and Mucin 16 to migration and survival of AsPC-1 human pancreatic cancer cells.	MUC16 MUC5B	6.94e-05	3	168	2	27230679
Pubmed	FLASH acts as a co-activator of the transcription factor c-Myb and localizes to active RNA polymerase II foci.	POLR2A MYB	6.94e-05	3	168	2	18408764
Pubmed	Src homology domain 2-containing protein-tyrosine phosphatase-1 (SHP-1) binds and dephosphorylates G(alpha)-interacting, vesicle-associated protein (GIV)/Girdin and attenuates the GIV-phosphatidylinositol 3-kinase (PI3K)-Akt signaling pathway.	PTPN6 CCDC88A	6.94e-05	3	168	2	21799016
Pubmed	GFI1B, EVI5, MYB--additional genes that cooperate with the human BCL6 gene to promote the development of lymphomas.	GFI1B MYB	6.94e-05	3	168	2	23910958
Pubmed	Histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) controls mammary gland development by regulating key developmental and lineage specification genes.	KDM5B FOXA1	6.94e-05	3	168	2	24802759
Pubmed	Where and what is the right shift factor or cerebral dominance gene? A critique of Francks et al. (2007).	PCDH11Y PCDH11X	6.94e-05	3	168	2	19125366
Pubmed	Doublecortin-Like Kinases Promote Neuronal Survival and Induce Growth Cone Reformation via Distinct Mechanisms.	DCLK2 DCLK1	6.94e-05	3	168	2	26526391
Pubmed	Non-clustered protocadherin.	PCDH11Y PCDH11X	6.94e-05	3	168	2	21173574
Pubmed	Interruption of TRPC6-NFATC1 signaling inhibits NADPH oxidase 4 and VSMCs phenotypic switch in intracranial aneurysm.	NOX4 NFATC1	6.94e-05	3	168	2	37002575
Pubmed	Alternative transcripts of Dclk1 and Dclk2 and their expression in doublecortin knockout mice.	DCLK2 DCLK1	6.94e-05	3	168	2	18075264
Pubmed	Phosphotyrosine phosphatases in GH-stimulated skin fibroblasts from children with idiopathic short stature.	PTPN1 PTPN6	6.94e-05	3	168	2	23729600
Pubmed	Oxygen-coupled redox regulation of the skeletal muscle ryanodine receptor-Ca2+ release channel by NADPH oxidase 4.	NOX4 RYR1	6.94e-05	3	168	2	21896730
Pubmed	The transcription factor NFAT4 is involved in the generation and survival of T cells.	NFATC1 NFATC3	6.94e-05	3	168	2	9768749
Pubmed	NFATc3 regulates the transcription of genes involved in T-cell activation and angiogenesis.	PTGS2 NFATC3	6.94e-05	3	168	2	21642596
Pubmed	The human cytoplasmic dynein interactome reveals novel activators of motility.	DYNC2I2 LIMD1 FPGS TTLL5 PTPN23 DDX27 MSTO1 SENP1 CCDC88A UBR5 NFATC3 ANKRD52 GARRE1 NIN	7.39e-05	853	168	14	28718761
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	STON1 LIMD1 CCDC88A UBR5 NFKB2 SEC16A PALLD	7.47e-05	209	168	7	36779422
Pubmed	Genetically distinct subsets within ANCA-associated vasculitis.	MXRA5 PCDH11Y PCDH11X	8.56e-05	18	168	3	22808956
Pubmed	Identification of Jmjd3 as an Essential Epigenetic Regulator of Hox Gene Temporal Collinear Activation for Body Axial Patterning in Mice.	KDM5B JMJD4 KDM5D JMJD1C	9.39e-05	49	168	4	34368113
Pubmed	Reduction of Nipbl impairs cohesin loading locally and affects transcription but not cohesion-dependent functions in a mouse model of Cornelia de Lange Syndrome.	PCDH11Y MAU2 PCDH11X	1.01e-04	19	168	3	23920377
Pubmed	Sequential involvement of NFAT and Egr transcription factors in FasL regulation.	NFATC1 NFATC3	1.38e-04	4	168	2	10755616
Pubmed	Nuclear factor of activated T cells is activated in the endothelium of retinal microvessels in diabetic mice.	NFATC1 NFATC3	1.38e-04	4	168	2	25918731
Pubmed	Novel JARID1C/SMCX mutations in patients with X-linked mental retardation.	KDM5B KDM5D	1.38e-04	4	168	2	16541399
Pubmed	NFAT isoforms play distinct roles in TNFα-induced retinal leukostasis.	NFATC1 NFATC3	1.38e-04	4	168	2	26527057
Pubmed	The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases.	KDM5B KDM5D	1.38e-04	4	168	2	17320160
Pubmed	The X-linked intellectual disability gene product and E3 ubiquitin ligase KLHL15 degrades doublecortin proteins to constrain neuronal dendritogenesis.	DCLK2 DCLK1	1.38e-04	4	168	2	33199366
Pubmed	Cloning and developmental expression of the murine homolog of the acute leukemia proto-oncogene AF4.	FGF5 AFF1	1.38e-04	4	168	2	9365243
Pubmed	HIV-1 gp120 induces NFAT nuclear translocation in resting CD4+ T-cells.	NFATC1 NFATC3	1.38e-04	4	168	2	16260021
Pubmed	Systematic study of constitutive cyclooxygenase-2 expression: Role of NF-κB and NFAT transcriptional pathways.	PTGS2 NFATC1	1.38e-04	4	168	2	26712011
Pubmed	Calcineurin regulates innate antifungal immunity in neutrophils.	NFATC1 NFATC3	1.38e-04	4	168	2	20421389
Pubmed	Distinct roles for neutrophils and dendritic cells in inflammation and autoimmunity in motheaten mice.	ITGAX PTPN6	1.38e-04	4	168	2	23521885
Pubmed	Defective T cell development and function in calcineurin A beta -deficient mice.	NFATC1 NFATC3	1.38e-04	4	168	2	12091710
Pubmed	Immunotherapy-based targeting of MSLN+ activated portal fibroblasts is a strategy for treatment of cholestatic liver fibrosis.	MUC16 THY1	1.38e-04	4	168	2	34253615
Pubmed	Alternative splicing and expression of human and mouse NFAT genes.	NFATC1 NFATC3	1.38e-04	4	168	2	18675896
Pubmed	Transcription factors of the NFAT family: regulation and function.	NFATC1 NFATC3	1.38e-04	4	168	2	9143705
Pubmed	Resident fibroblast lineages mediate pressure overload-induced cardiac fibrosis.	TBX18 NFATC1	1.38e-04	4	168	2	24937432
Pubmed	Calcineurin Aβ regulates NADPH oxidase (Nox) expression and activity via nuclear factor of activated T cells (NFAT) in response to high glucose.	NOX4 NFATC1	1.38e-04	4	168	2	24371139
Pubmed	Src kinase activity is regulated by the SHP-1 protein-tyrosine phosphatase.	PTPN1 PTPN6	1.38e-04	4	168	2	9261115
Pubmed	Normal B-1a cell development requires B cell-intrinsic NFATc1 activity.	NFATC1 NFATC3	1.38e-04	4	168	2	14595020
Pubmed	Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells.	NFATC1 NFATC3	1.38e-04	4	168	2	22991461
Pubmed	Impaired conditioned fear and enhanced long-term potentiation in Fmr2 knock-out mice.	AFF3 AFF1	1.38e-04	4	168	2	11923441
Pubmed	The transcription factor nuclear factor of activated T cells c3 modulates the function of macrophages in sepsis.	NFATC1 NFATC3	1.38e-04	4	168	2	24970700
Pubmed	Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss.	CACNA1F TTLL5 BBS2 CD46 NPHP4 PTPN6 DGCR8	1.47e-04	233	168	7	32290105
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	DYNC2I2 LIMD1 ARRDC1 POLR2A N4BP3 ANKRD54 AAAS CCDC88A MROH6 UBR5 BTBD7 NFKB2 SEC16A HEATR5B ANKRD52	1.66e-04	1038	168	15	26673895
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	KDM5B CRIM1 TTLL5 WHAMM ZNF202 SMG5 DDX27 MSTO1 ANKRD54 ARG2 CNPPD1 GUCY1B1 DCLK2 DGCR8 DCLK1 DKK3 RNF111	1.74e-04	1285	168	17	35914814
Pubmed	Down syndrome critical region-1 is a transcriptional target of nuclear factor of activated T cells-c1 within the endocardium during heart development.	NFATC1 NFATC3	2.30e-04	5	168	2	17693409
Pubmed	Expression of human endogenous retrovirus type K (HML-2) is activated by the Tat protein of HIV-1.	NFATC1 NFATC3	2.30e-04	5	168	2	22593154
Pubmed	The cell-layer- and cell-type-specific distribution of GalNAc-transferases in the ocular surface epithelia is altered during keratinization.	GALNT6 GALNT4	2.30e-04	5	168	2	12506059
Pubmed	Dismissal of RNA Polymerase II Underlies a Large Ligand-Induced Enhancer Decommissioning Program.	POLR2A FOXA1	2.30e-04	5	168	2	30118678
Pubmed	STAT3 cooperates with the non-canonical NF-κB signaling to regulate pro-labor genes in the human placenta.	PTGS2 NFKB2	2.30e-04	5	168	2	25771405
Pubmed	Distinct roles of prostaglandin H synthases 1 and 2 in T-cell development.	PTGS2 THY1	2.30e-04	5	168	2	10330429
Interaction	FBLN5 interactions	TTLL5 POLR2A HOXA1 GFI1B PHC3 SENP1 PRR14L DGCR8 RNF111 ALG13	7.29e-07	159	164	10	int:FBLN5
Cytoband	Ensembl 112 genes in cytogenetic band chr9q34	TMEM250 DDX31 DYNC2I2 ARRDC1 FPGS GFI1B SEC16A ST6GALNAC4	2.89e-05	325	168	8	chr9q34
Cytoband	11q23.3	NLRX1 ZNF202 THY1 POU2F3	2.00e-04	78	168	4	11q23.3
GeneFamily	Protein tyrosine phosphatases, non-receptor type	PTPN23 PTPN1 PTPN6	1.86e-04	18	114	3	812
GeneFamily	AF4/FMR2 family\|Super elongation complex	AFF3 AFF1	2.35e-04	4	114	2	1145
GeneFamily	Nuclear factors of activated T-cells	NFATC1 NFATC3	3.89e-04	5	114	2	665
GeneFamily	PHD finger proteins\|Lysine demethylases	KDM5B KDM5D JMJD1C	4.49e-04	24	114	3	485
GeneFamily	AF4/FMR2 family\|Super elongation complex	AFF3 AFF1	1.38e-03	9	114	2	1280
GeneFamily	Doublecortin superfamily	DCLK2 DCLK1	1.72e-03	10	114	2	1369
GeneFamily	Zinc fingers C2H2-type\|SNAG transcriptional repressors	GFI1B INSM2	1.72e-03	10	114	2	1259
GeneFamily	Maestro heat like repeat containing	MROH1 MROH6	2.09e-03	11	114	2	636
GeneFamily	DEAD-box helicases	DDX31 DDX51 DDX27	2.34e-03	42	114	3	499
GeneFamily	Non-clustered protocadherins	PCDH11Y PCDH11X	2.50e-03	12	114	2	21
GeneFamily	AT-rich interaction domain containing	KDM5B KDM5D	3.92e-03	15	114	2	418
GeneFamily	Ankyrin repeat domain containing	ESPN ANKRD54 ASB5 NFKB2 ANKRD52 MYO16	4.33e-03	242	114	6	403
GeneFamily	Polypeptide N-acetylgalactosaminyltransferases	GALNT6 GALNT4	6.95e-03	20	114	2	433
GeneFamily	CD molecules\|Mucins	MUC16 MUC5B	7.65e-03	21	114	2	648
Coexpression	PEREZ_TP53_TARGETS	ESPN ABHD15 MXRA5 DDX31 DYNC2I2 LIMD1 MARCHF8 PLK5 AFF3 TTYH2 ADCY1 ARG2 NRBP2 HOXC13 DUOXA1 LRP10 UCKL1 AFF1 INSM2 DCLK1 MYB FAM149A	8.42e-06	1201	167	22	M4391
Coexpression	GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN	CRIM1 MARCHF8 ITGAX SEC16A CLEC2D CD70 DCLK1 RNF111	1.18e-05	166	167	8	M6701
CoexpressionAtlas	gamma delta T cells, Tgd.vg2-.Sp, TCRd+ Vg2- CD44-, Spleen, avg-3	KDM5B CRIM1 AFF3 AKNA PELI1 ZNF831 CD6 THY1 RASAL3 NFATC3 GAB3 PRR14L GALNT6 PATJ MYB	3.20e-07	382	165	15	GSM476684_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg2-.Sp.TCRbko, TCRd+ Vg2- CD44-, Spleen, avg-3	KDM5B CRIM1 AFF3 AKNA ZNF831 CD6 THY1 LRP10 NFATC1 NFATC3 GAB3 GALNT6 PATJ MYB	3.57e-06	405	165	14	GSM605796_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg2+.Sp.TCRbko, TCRd+ Vg2+ CD44-, Spleen, avg-3	CCNJL KDM5B CRIM1 AFF3 CD6 THY1 RASAL3 LRP10 GAB3 PRR14L GALNT6 PATJ MYB	1.13e-05	388	165	13	GSM605790_500
CoexpressionAtlas	alpha beta T cells, T.DP69+.Th, 4+ 8+ TCRlo/int 69+, Thymus, avg-3	CCNJL KDM5B HIVEP3 CD6 SHF THY1 RASAL3 LRP10 DCLK2 GALNT6 MYB	2.78e-05	305	165	11	GSM399394_500
CoexpressionAtlas	CD positive, CD4 Control, 4+ 8- B220-, Spleen, avg-4	CRIM1 AFF3 PELI1 ZNF831 CD6 THY1 RASAL3 GALNT6 PATJ	4.03e-05	210	165	9	GSM403995_500
CoexpressionAtlas	gamma delta T cells, Tgd.vg2+.Sp, TCRd+ Vg2+ CD44-, Spleen, avg-3	KDM5B CRIM1 AFF3 PELI1 CD6 THY1 RASAL3 NFATC3 GAB3 GALNT6 PATJ MYB	5.11e-05	386	165	12	GSM605787_500
CoexpressionAtlas	alpha beta T cells, T.4.Pa.BDC, 4+ 8- BDC+, Pancreas, avg-2	KDM5B CRIM1 AFF3 PELI1 ZNF831 CD6 THY1 RASAL3 GALNT6 PATJ MYB	5.38e-05	328	165	11	GSM605756_500
CoexpressionAtlas	alpha beta T cells, T.DPsm.Th, 4+ 8+ TCR-/lo FSClo, Thymus, avg-3	KDM5B AFF3 ZC3H12B AXDND1 CD6 THY1 NFATC3 AFF1 DCLK2 PATJ MYB	8.02e-05	343	165	11	GSM399400_500
CoexpressionAtlas	CD positive, CD4 Test NA, 4+8-B220-, Spleen, avg-1	KDM5B CRIM1 AFF3 PELI1 ZNF831 CD6 THY1 RASAL3 NFATC3 GALNT6 PATJ	1.14e-04	357	165	11	GSM403986_500
ToppCell	21-Trachea-Epithelial-Submucosal_gland_basal\|Trachea / Age, Tissue, Lineage and Cell class	NOX4 THSD7B UCN2 THY1 GUCY1B1 CD70 DKK3 MYO16	1.60e-07	159	167	8	4f670b57b8d3b090ea2f1aafe15baf93cb7ef146
ToppCell	severe-CD4+_T_naive\|severe / disease stage, cell group and cell class	BBS2 CD6 L3MBTL1 SORCS3 CACNA1I PATJ GARRE1 MYB	2.34e-07	167	167	8	02a8215fca59c357c1cdaa5738849eacf98c0bcc
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Immune\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AFF3 AKNA ZNF831 ITGAX CD6 RASAL3 CD163L1 CLEC2D	7.58e-07	195	167	8	7b6c69df943842b566a596e30bb50dbe80dccc83
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Mucous-Mucous\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	AFF3 MUC16 MUC5B FOXA1 SEC16A SCNN1A GALNT6 GALNT4	7.88e-07	196	167	8	357a5440aeebf69688bfe9fbc8585950ad00906b
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Mucous\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	AFF3 MUC16 MUC5B FOXA1 SEC16A SCNN1A GALNT6 GALNT4	7.88e-07	196	167	8	98e3f9c886063def16c74ab75fc81511a7872f1c
ToppCell	Control-Control-Myeloid-Neutrophil\|Control / Disease, condition lineage and cell class	CCNJL MBOAT7 PELI1 ITGAX JMJD1C PTGS2 MYO16 NIN	9.17e-07	200	167	8	95c41f147a1594d49e73cb56d86d301c3115ce20
ToppCell	COVID-19-kidney-Technical/muscle_(EC)\|kidney / Disease (COVID-19 only), tissue and cell type	STXBP5L PCDH11Y MUC16 TEX15 THSD7B RYR1 HOXC13	9.68e-07	139	167	7	64c35411bbe67acb5010dadc4b0b1be0f8b17737
ToppCell	TCGA-Thymus-Primary_Tumor-Thymoma-Type_C\|TCGA-Thymus / Sample_Type by Project: Shred V9	MUC16 FOXA1 PTGS2 GFI1B TMEM132A CD70 POU2F3	2.80e-06	163	167	7	2dac87d15051151ccf193760ddd8b82534c3f922
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	AKNA ITGAX CCDC88A RASAL3 DPEP3 GAB3 MYB	4.00e-06	172	167	7	f6b4754a7e4b3e38030316a0ae00d932bfa87e41
ToppCell	facs-Lung-nan-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTLL5 AKNA ZNF202 THSD7B CD6 THY1 GALNT6	4.31e-06	174	167	7	1c073177c1753e3b91ef8fd9e95230a1d13c82f3
ToppCell	facs-Lung-nan-3m-Lymphocytic-CD8+_T\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TTLL5 AKNA ZNF202 THSD7B CD6 THY1 GALNT6	4.31e-06	174	167	7	5491ad5c144baf2ef9b1c58eb720c872d14feb15
ToppCell	E17.5-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CRIM1 MUC16 PKHD1L1 SLC1A7 TBX18 FGF5 FLRT1	6.23e-06	184	167	7	607b55022de21ddb6a2d75e085df76df7abf6624
ToppCell	droplet-Lung-immune-endo-depleted-3m-Epithelial-lung_neuroendocrine_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESPN STXBP5L FOXA1 ADCY1 FGF5 FLRT1 IGSF1	6.45e-06	185	167	7	30263c558ee331e0879abcf8b4c2427ff05f9fe7
ToppCell	droplet-Lung-immune-endo-depleted-3m-Epithelial-Neuroendocrine\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESPN STXBP5L FOXA1 ADCY1 FGF5 FLRT1 IGSF1	6.45e-06	185	167	7	1b000ca11970db8f347eb97ff44605d562aea70a
ToppCell	facs-Lung-ENDOMUCIN-18m-Lymphocytic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESPN AKNA PTPN6 THY1 RASAL3 NFATC3 GALNT6	6.68e-06	186	167	7	6e3bea4319d2a1bb060fe0cb1bb8bafafa05f83c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MARCHF8 AFF3 PELI1 N4BP3 PTPN1 NFKB2 CD70	8.50e-06	193	167	7	bbea475d2c4c7b29674ff302529f8f83dd666dcb
ToppCell	Transverse-B_cell-B_cell_IgG_Plasma\|B_cell / Region, Cell class and subclass	MUC16 HEATR5A LHB PTPN1 SENP1 NDUFV1-DT POU2F3	9.72e-06	197	167	7	a0a096e8e80763a92d5d7396eb678a4587771a3a
ToppCell	LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	CACNA1F HEATR5A PTPN1 PCDH11X SCNN1A PATJ DCLK1	9.72e-06	197	167	7	b94645d57efe8d9e032bffb8c89af1f425c6421e
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	AKNA ZNF831 PTPN1 CD6 RASAL3 CLEC2D GAB3	1.07e-05	200	167	7	5f41906cf1585e09b150a84364d47c3e466dc5b7
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma-3\|TCGA-Brain / Sample_Type by Project: Shred V9	ARRDC1 MARCHF8 HEATR5A NPHP4 JMJD1C UBR5	1.21e-05	135	167	6	3351e8b9e417397c5fa9f856184ff24ce1a27242
ToppCell	TCGA-Breast\|World / Sample_Type by Project: Shred V9	AFF3 FOXA1 N4BP3 CT62 GALNT6 MYB	2.20e-05	150	167	6	08686ba1acac5c58667bf62e2af84c691d6bbdfb
ToppCell	droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-NK_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NLRX1 NPHP4 ITGAX RYR1 PTPN1 DPEP3	2.37e-05	152	167	6	82a493ffb2f1704cd6f68a82d970fe12f537d20e
ToppCell	5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	AFF3 THSD7B FANCA CCDC88A UBR5 NIN	2.74e-05	156	167	6	203ef22eb76bd2b829b027c30af0557080f4006c
ToppCell	droplet-Liver-LIVER_HEPATOCYTES-30m-Lymphocytic-NK/T\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF831 LRFN4 CD6 THY1 CD163L1 FGF5	3.27e-05	161	167	6	140b3c7077947c541cff54f6754e2df968345f4d
ToppCell	droplet-Heart-nan-24m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ITGAX RYR1 FANCA CD6 RASAL3 MYB	3.27e-05	161	167	6	7e60001637ef0f6fc67ef8a36ab80ebb25b0b0ab
ToppCell	COVID-19-kidney-Technical/muscle_(Imm)\|kidney / Disease (COVID-19 only), tissue and cell type	STXBP5L THSD7B ZNF831 RYR1 DCLK1 MYO16	3.51e-05	163	167	6	19c28ce16a588a7f4a035c32726f6ccd67702b5b
ToppCell	facs-MAT-Fat-24m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PELI1 CD6 THY1 RASAL3 GALNT6 PATJ	3.63e-05	164	167	6	e9e34c305c943675688e54ab331c2bdefb2fac68
ToppCell	mild_COVID-19_(asymptomatic)-B_cell\|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2)	CCNJL ARG2 SHF L3MBTL1 GUCY1B1 ST6GALNAC4	3.63e-05	164	167	6	e4d43af7eb04d55328791b554bdf3a7ce6818027
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ESPN PRR5 THY1 RASAL3 CD163L1 GAB3	3.75e-05	165	167	6	0c80abf13409767825ef8a507b498afafa7e89c5
ToppCell	E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ESPN PRR5 THY1 RASAL3 CD163L1 GAB3	3.75e-05	165	167	6	cced77f2d74b07010307d7f4788b8cf3fdaeb91a
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|356C / Donor, Lineage, Cell class and subclass (all cells)	CACNA1F ZNF48 AASDH ZNF831 CLEC2D CD70	3.88e-05	166	167	6	c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKNA NPHP4 ITGAX RYR1 LMLN SCNN1A	4.43e-05	170	167	6	8e774af244cfe787fa0ea2b6be0c3c2d00bfe4fc
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF831 GFI1B PTPN6 FGF5 POU2F3 DCLK1	4.43e-05	170	167	6	17bd7fd25a2657cb536ad47e294332920f759e95
ToppCell	droplet-Lung-immune-endo-depleted-3m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKNA NPHP4 ITGAX RYR1 LMLN SCNN1A	4.43e-05	170	167	6	f5140eb9313c0d1bb31f8a761d9c062c56733a61
ToppCell	356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CACNA1F ZNF48 AASDH ZNF831 ARG2 SCNN1A	4.73e-05	172	167	6	a9e13aa36087170dadca421ba9de588e5a1cf715
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MUC16 PKHD1L1 SLC1A7 TBX18 FGF5 FLRT1	4.89e-05	173	167	6	ee7d1429f23f1b89a9a9f7bc07a84a44cf7acd1c
ToppCell	PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MUC16 PKHD1L1 SLC1A7 TBX18 FGF5 FLRT1	4.89e-05	173	167	6	3725525b99a6011eda2ff5459b4fd2e1eab1f090
ToppCell	facs-Large_Intestine-Distal-24m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESPN CACNA1F GFI1B PTPN6 POU2F3 DCLK1	4.89e-05	173	167	6	f0eb48c1283bdde313bb75f6ffc0d2626922d24b
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CRIM1 MUC16 PKHD1L1 SLC1A7 TBX18 FGF5	4.89e-05	173	167	6	30d67738633493d47f06ae452424382f069b6c0a
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AKNA ZNF831 CD6 RASAL3 CLEC2D CD70	5.05e-05	174	167	6	47e308a777c927ae69ed344cb3dd8561bf2c48a5
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CRIM1 MUC16 PKHD1L1 SLC1A7 TBX18 FGF5	5.05e-05	174	167	6	a9c6edf5c3fc119c24425f921c5566a8356c30fe
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Immune-Lymphocytic_T/NK-T_Cell-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	AKNA ZNF831 CD6 RASAL3 CLEC2D CD70	5.05e-05	174	167	6	a92c745d20633909db0f08effa13fc738fda79a6
ToppCell	facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABHD15 POLR2A FANCA LRFN4 SYTL4 AFF1	5.05e-05	174	167	6	f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d
ToppCell	Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)\|Striatum / BrainAtlas - Mouse McCarroll V32	NOX4 ASB5 AP5B1 POU2F3 PALLD	5.20e-05	107	167	5	d4807f008619dfd3e215d602df0d02b135b1ac37
ToppCell	Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1-MURAL_Mural.Rgs5Acta2.Cnn1_(Mural.Rgs5Acta2.Cnn1)-\|Striatum / BrainAtlas - Mouse McCarroll V32	NOX4 ASB5 AP5B1 POU2F3 PALLD	5.20e-05	107	167	5	5907b9632c88d48f293c3c6d37b7ef831fbcdd86
ToppCell	Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_1\|Striatum / BrainAtlas - Mouse McCarroll V32	NOX4 ASB5 AP5B1 POU2F3 PALLD	5.20e-05	107	167	5	3f24de1afbfd070f9db11c9acd02b90e5eb2511d
ToppCell	facs-Large_Intestine-Distal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESPN GFI1B PTPN6 NFATC1 POU2F3 DCLK1	5.21e-05	175	167	6	f24b664b9056b5976bf2222e8013f15c09e049ad
ToppCell	droplet-Lung-21m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SERTAD2 MUC5B CD6 THY1 DGCR8 MYB	5.38e-05	176	167	6	91ad2c34144f72283ca112fd3b3784f2f6259f65
ToppCell	facs-MAT-Fat-3m-Lymphocytic-CD8-positive,_alpha-beta_T_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PELI1 CD6 THY1 RASAL3 GALNT6 PATJ	5.38e-05	176	167	6	77c6103639acd0f3d6a2171c5f37a8083b6c2cf0
ToppCell	Fetal_29-31_weeks-Epithelial-club_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CRIM1 CD46 FOXA1 INSM2 PATJ FAM149A	5.38e-05	176	167	6	3bbac5c2397535631fce8fa98f6ddb4fe0260351
ToppCell	facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	STXBP5L NLRX1 AASDH THSD7B L3MBTL1 DCLK2	5.55e-05	177	167	6	8abdf1d970b2f15e17e185f3e612dd5065c88757
ToppCell	facs-MAT-Fat-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKNA CD6 THY1 RASAL3 GALNT6 MYB	5.55e-05	177	167	6	b5c20c1247f11ebc97e9cb47482564cd74e36ca6
ToppCell	droplet-Kidney-KIDNEY-1m-Lymphocytic-T_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PELI1 ZC3H12B ZNF831 CD6 THY1 RASAL3	5.55e-05	177	167	6	36da06ca9577cdb7c7b5114e604f6546b9765c08
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-B_cells-Pre-B\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ABHD15 AFF3 PTPN6 RASAL3 CD70 MYB	5.73e-05	178	167	6	8545c0238d8d833a6a179872d44bfb739310ea17
ToppCell	facs-Large_Intestine-Proximal-18m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ESPN GFI1B PTPN6 NFATC1 POU2F3 DCLK1	5.73e-05	178	167	6	09a215a0d6e98e4bb920cabda12af08ff4de3c98
ToppCell	Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	ZNF831 UCN2 FANCA SCNN1A FGF5	5.93e-05	110	167	5	438bf761ab0a25e3dc9244c23ae2c2d68a169c7f
ToppCell	Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	ZNF831 UCN2 FANCA SCNN1A FGF5	5.93e-05	110	167	5	3639fb5fc02eca509cb220295bc3e6064c23baab
ToppCell	Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.Zbtb20_(Ventral_Hippocampus)\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	ZNF831 UCN2 FANCA SCNN1A FGF5	5.93e-05	110	167	5	ff196c71aa2a21cdd812958bd163fa6b91bd2352
ToppCell	Entopeduncular-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Excitatory_Neuron.Slc17a7.Zbtb20_(Ventral_Hippocampus)-\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	ZNF831 UCN2 FANCA SCNN1A FGF5	5.93e-05	110	167	5	46635a130453c2fa304f0e09561b2a267c9ceb31
ToppCell	Adult-Immune-T_lymphocyte-D122\|Adult / Lineage, Cell type, age group and donor	AKNA ZNF831 CD6 RASAL3 CLEC2D CACNA1I	6.09e-05	180	167	6	06c371d0f0c5a7b234dd143e98800e19af95a8b5
ToppCell	P03-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MUC16 PKHD1L1 SLC1A7 TBX18 FGF5 GALNT6	6.09e-05	180	167	6	2ccc77d769d3ffd77ab3af45e4f192785b6db79c
ToppCell	Transverse-Dendritic_cell-cDC2\|Dendritic_cell / Region, Cell class and subclass	AKNA ITGAX PTPN6 GAB3	6.20e-05	57	167	4	8d1ee7e3cfea05418f3a64edc07a76f3cbb1a471
ToppCell	saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DDX31 PRR5 KDM5D CD6 CLEC2D DKK3	6.28e-05	181	167	6	986c036e656f24fe374807e2711cec9e3c83c892
ToppCell	wk_15-18-Hematologic-Meg-ery-Definitive_erythroblast\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ESPN MARCHF8 PRR5 SERTAD2 KDM5D OSBP2	6.48e-05	182	167	6	93841f730ca1a735eaaf5f2ccbe5c45ab0e029d1
ToppCell	wk_20-22-Hematologic-Meg-ery-Definitive_erythroblast\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ESPN MARCHF8 SERTAD2 GFI1B FLCN OSBP2	6.48e-05	182	167	6	0c77ef4556c1d1512ebe9077df858b28f9e38dd5
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F STXBP5L MUC5B PKHD1L1 PCDH11X MYO16	6.88e-05	184	167	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ESPN STXBP5L FOXA1 ADCY1 FLRT1 IGSF1	6.88e-05	184	167	6	e0e5a553fb8c0947679634396d20c2ca8455b932
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F STXBP5L MUC5B PKHD1L1 PCDH11X MYO16	6.88e-05	184	167	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	droplet-Lung-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ESPN STXBP5L FOXA1 ADCY1 FLRT1 IGSF1	6.88e-05	184	167	6	c3b848e1438a84b3fac8a4e40f3db478cc84d970
ToppCell	droplet-Kidney-KIDNEY-1m-Lymphocytic-CD45____T_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PELI1 ZC3H12B CD6 THY1 RASAL3 GAB3	6.88e-05	184	167	6	2c8e9ddce3e60302965dcf9dee77c4fe33e4071d
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CACNA1F STXBP5L MUC5B PKHD1L1 PCDH11X MYO16	6.88e-05	184	167	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	COVID_non-vent-Myeloid-Monocytic-Neutrophil\|COVID_non-vent / Disease condition, Lineage, Cell class and subclass	CCNJL MBOAT7 PELI1 ITGAX PTGS2 LRP10	7.09e-05	185	167	6	2c89af7cdf5306b900a5b8ec4fdfb8210e5667ed
ToppCell	facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KDM5B HIVEP3 CD6 RASAL3 LRP10 GALNT6	7.09e-05	185	167	6	a2cae8c657e4f4d121476798e424876f7e247973
ToppCell	facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KDM5B HIVEP3 CD6 RASAL3 LRP10 GALNT6	7.09e-05	185	167	6	d50406a9a5b8d75110ba5985741aa2293950c543
ToppCell	PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-erythro\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	ESPN CNPPD1 GFI1B FLCN ST6GALNAC4 OSBP2	7.30e-05	186	167	6	34ed60e846fd83fab3e28dc9e278bcc4b092a9f0
ToppCell	facs-SCAT-Fat-3m-Lymphocytic-B_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	AKNA ZNF831 PTPN6 RASAL3 NFATC3 CACNA1I	7.30e-05	186	167	6	d5d990d8b6ccd8ca8fe7d0d7dedbe2359ae7b582
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SEMA6B MUC16 JMJD1C PTGS2 CCDC88A SORCS3	7.30e-05	186	167	6	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|368C / Donor, Lineage, Cell class and subclass (all cells)	CCNJL LIMD1 FOXA1 LMLN SCNN1A PATJ	7.52e-05	187	167	6	b827d9da7032bf051756ddf88352af922eb0f87b
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	CCNJL LIMD1 FOXA1 LMLN SCNN1A PATJ	7.52e-05	187	167	6	61c00604dda8b36a5c3eea6554e5601aa1b884f7
ToppCell	Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PRR5 PELI1 ITGAX RYR1 CD163L1 AFF1	7.75e-05	188	167	6	3be2d50148daa4eddddc2c7f269f45c97f7e4931
ToppCell	368C-Epithelial_cells-Epithelial-I_(AT1)\|368C / Donor, Lineage, Cell class and subclass (all cells)	TMEM250 DYNC2I2 TEP1 NPHP4 SYTL4 PATJ	7.75e-05	188	167	6	9155b9a92496e75646778c025b02947e9e9ec73a
ToppCell	368C-Epithelial_cells-Epithelial-I_(AT1)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	TMEM250 DYNC2I2 TEP1 NPHP4 SYTL4 PATJ	7.75e-05	188	167	6	c74771584b3ba9561a99a54bf55a9203ddf8eff8
ToppCell	Children_(3_yrs)-Immune-T_lymphocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	AKNA ZNF831 CD6 RASAL3 CLEC2D CACNA1I	7.98e-05	189	167	6	df30478b288084a1bd48f660409dcc784040897c
ToppCell	COPD\|World / Disease state, Lineage and Cell class	STON1 AKNA PELI1 ZNF831 CD6 CLEC2D	7.98e-05	189	167	6	53577632683686dc493a5a3fdc01887ec5c320f2
ToppCell	BAL-Control-Lymphocyte-B-B_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNF48 HIVEP3 NFATC1 POLR3E NFKB2 CD70	8.21e-05	190	167	6	da7341a8a423e5fe4d8e733d8e50c10a3318ac1c
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNF48 HIVEP3 NFATC1 POLR3E NFKB2 CD70	8.21e-05	190	167	6	42312f7d79fe889397d32910b625793e2535cc26
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	DYNC2I2 AFF3 PELI1 PTPN1 NFKB2 CD70	8.21e-05	190	167	6	0db545a4cba7534bad2693e0d565cde7dbc7a586
ToppCell	mild-Others\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MBOAT7 ITGAX GFI1B GUCY1B1 SYTL4 OSBP2	8.21e-05	190	167	6	782dc1b612ac1faad7cc2781bfda92a079830d38
ToppCell	BAL-Control-Lymphocyte-B-B_cell-B_cell-B_activate-7\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ZNF48 HIVEP3 NFATC1 POLR3E NFKB2 CD70	8.21e-05	190	167	6	682418a7a2096743112eae3790d40e7e600612c0
ToppCell	COVID-19-kidney-T-cells-2\|kidney / Disease (COVID-19 only), tissue and cell type	AKNA ZNF831 CD6 CLEC2D CD70 MYB	8.45e-05	191	167	6	698e6a28276704f8baa082d028db2345b973c4bc
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	AKNA ZNF831 CD6 RASAL3 CLEC2D CD70	8.45e-05	191	167	6	d9506b88d806aadd4c2b9bf86fe994c47799e7f6
ToppCell	ILEUM-non-inflamed-(6)_ILC3\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	ABHD15 MBOAT7 AFF3 PRR5 PTGS2 VWA3B	8.45e-05	191	167	6	6eaf72b41084404bee0db04e4605db745a74995f
ToppCell	mild-Others-Megakaryocytes\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	MBOAT7 ITGAX GFI1B GUCY1B1 SYTL4 OSBP2	8.45e-05	191	167	6	0b36223bd7f5758cc37194da6cc252f613bc3c97
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	AKNA ZNF831 CD6 RASAL3 CLEC2D CD70	8.45e-05	191	167	6	9aabbc65430e2233b8f2d3fff9face7807b88b48
ToppCell	control-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CCNJL MBOAT7 PELI1 ITGAX JMJD1C PTGS2	8.45e-05	191	167	6	db1b3cd07d7d190155b2d14e82e1d124975fbd0b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Immune-Lymphocytic_T/NK-T_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	AKNA ZNF831 CD6 RASAL3 CLEC2D CD70	8.45e-05	191	167	6	b42c54308abe1241cc38ddce96b9d38d07983891
ToppCell	Adult-Immune-natural_killer_cell\|Adult / Lineage, Cell type, age group and donor	PRR5 AKNA ZNF831 CD6 RASAL3 CLEC2D	8.45e-05	191	167	6	758ec27e47d7662a5175305e98a1506c6859dbf7
ToppCell	Healthy_Control-Lymphoid-T-CD8_T\|Healthy_Control / Condition, Lineage, Cell class and cell subclass	PRR5 AKNA ZNF831 CD6 RASAL3 CLEC2D	8.70e-05	192	167	6	36b6ea21b0b1342f2dcac4dcaf359b6c772203f7
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Mesenchymal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CRIM1 LIMD1 TBX18 GUCY1B1 POU2F3 PALLD	8.70e-05	192	167	6	e5117cdb8af220f60bd1410262078c0306667b4a
ToppCell	wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ESPN MARCHF8 SERTAD2 KDM5D GFI1B OSBP2	8.95e-05	193	167	6	be75abfdf5301cf33df8ee9ed92504d44fdf19a6
Drug	S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; PC3; HT_HG-U133A	DDX31 FPGS NLRX1 JMJD4 CNPPD1 HOXC13 NFATC3 TMEM132A FGF5 IQCE	1.84e-06	196	166	10	6299_DN
Drug	Withaferin A [5119-48-2]; Down 200; 1uM; MCF7; HT_HG-U133A	RABEP2 STON1 TTLL5 N4BP3 SLC1A7 FANCA HIVEP3 NFKB2 MYB	9.39e-06	186	166	9	3902_DN
Drug	Felbinac [5728-52-9]; Down 200; 18.8uM; MCF7; HT_HG-U133A	JMJD4 N4BP3 SLC1A7 HOXC13 NFATC3 NFKB2 FLCN CD70 IQCE	1.43e-05	196	166	9	5700_DN
Drug	Esculin Hydrate [531-75-9]; Down 200; 11.8uM; MCF7; HT_HG-U133A	CRIM1 ZNF202 SLC1A7 CNPPD1 LRFN4 NFATC3 NFKB2 IGSF1 PATJ	1.43e-05	196	166	9	5411_DN
Drug	Labetalol hydrochloride [32780-64-6]; Up 200; 11uM; MCF7; HT_HG-U133A	MXRA5 STXBP5L TTLL5 PCDHA2 N4BP3 TEP1 PHC3 CD6 FAM149A	1.68e-05	200	166	9	3167_UP
Drug	AC1NBU2S	CACNA1F LTB4R2 PTGS2 RYR1 GUCY1B1 NFKB2 CACNA1I	2.44e-05	117	166	7	CID004473765
Drug	Retinoic acid [302-79-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A	DDX51 HOXA1 PHC3 L3MBTL1 HOXC13 NFATC3 SCNN1A PATJ	6.60e-05	185	166	8	6243_UP
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	STON1 PRR5 SMG5 SLC1A7 NFATC1 BTBD7 DGCR8 PATJ	8.56e-05	192	166	8	4450_DN
Drug	17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A	EMC1 DDX31 PRR5 ADCY1 SLC1A7 LRFN4 HOXC13 MYB	8.88e-05	193	166	8	5215_DN
Drug	Equilin [474-86-2]; Down 200; 15uM; MCF7; HT_HG-U133A	RABEP2 EMC1 TTLL5 TEP1 SLC1A7 PHC3 NFATC3 FLCN	9.20e-05	194	166	8	3377_DN
Drug	Procarbazine hydrochloride [366-70-1]; Down 200; 15.6uM; HL60; HT_HG-U133A	EMC1 ZNF202 SMG5 SLC1A7 HOXA1 PHC3 AAAS PRR14L	9.54e-05	195	166	8	2971_DN
Drug	Clorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A	EMC1 MBOAT7 JMJD4 PHC3 BTBD7 FLCN PRR14L MYB	9.54e-05	195	166	8	2884_DN
Drug	Retrorsine [480-54-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A	MXRA5 STXBP5L NLRX1 AFF3 CD6 L3MBTL1 SCNN1A CD70	9.88e-05	196	166	8	2784_UP
Drug	Carbenoxolone disodium salt [7421-40-1]; Down 200; 6.6uM; MCF7; HT_HG-U133A	EMC1 TTLL5 NLRX1 N4BP3 FANCA HIVEP3 PHC3 CD6	9.88e-05	196	166	8	3353_DN
Drug	Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A	RABEP2 LIMD1 CNPPD1 AAAS TMEM132A CD70 ST6GALNAC4 MYB	9.88e-05	196	166	8	2090_DN
Drug	Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A	LIMD1 TTLL5 NLRX1 JMJD4 SMG5 PHC3 BTBD7 MYB	9.88e-05	196	166	8	2315_DN
Drug	Cinchonine [118-10-5]; Up 200; 13.6uM; HL60; HT_HG-U133A	CRIM1 DDX51 SLC1A7 HOXA1 PHC3 CCDC88A CACNA1I DGCR8	9.88e-05	196	166	8	2133_UP
Drug	Metergoline [17692-51-2]; Down 200; 10uM; PC3; HT_HG-U133A	STON1 TTLL5 CD6 L3MBTL1 BTBD7 CACNA1I ST6GALNAC4 PATJ	9.88e-05	196	166	8	6744_DN
Drug	CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A	RABEP2 FPGS PRR5 FANCA ARG2 L3MBTL1 PATJ IQCE	9.88e-05	196	166	8	7502_UP
Drug	Propylthiouracil [51-52-5]; Up 200; 23.4uM; MCF7; HT_HG-U133A	RABEP2 CRIM1 TEP1 PHC3 FLCN CD70 PATJ MYB	9.88e-05	196	166	8	2837_UP
Drug	Sulfanilamide [63-74-1]; Down 200; 23.2uM; PC3; HT_HG-U133A	MUC5B TEX15 ARG2 PHC3 BTBD7 FGF5 DGCR8 IQCE	1.02e-04	197	166	8	4474_DN
Drug	Glycopyrrolate [596-51-0]; Down 200; 10uM; PC3; HT_HG-U133A	DDX31 JMJD4 ZNF202 NFATC1 BTBD7 TMEM132A FLCN FGF5	1.02e-04	197	166	8	7386_DN
Drug	Diethylstilbestrol [56-53-1]; Down 200; 15uM; PC3; HT_HG-U133A	CCNJL SMG5 TEP1 SLC1A7 HOXA1 CD70 OSBP2 MYB	1.02e-04	197	166	8	4547_DN
Drug	5186223; Down 200; 12uM; MCF7; HT_HG-U133A_EA	TTLL5 JMJD4 ZNF202 PHC3 PTPN6 CD6 NFKB2 IQCE	1.02e-04	197	166	8	885_DN
Drug	Meclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A	DDX51 HIVEP3 CD6 SCNN1A FGF5 CACNA1I OSBP2 FLRT1	1.02e-04	197	166	8	3605_UP
Drug	Furosemide [54-31-9]; Down 200; 12uM; PC3; HT_HG-U133A	RABEP2 MUC5B SMG5 TMEM132A CD70 CACNA1I ST6GALNAC4 DGCR8	1.02e-04	197	166	8	4503_DN
Drug	Amidopyrine [58-15-1]; Down 200; 17.2uM; PC3; HT_HG-U133A	RABEP2 TTLL5 SMG5 HOXA1 AAAS FLCN CD70 ALG13	1.02e-04	197	166	8	2060_DN
Drug	Trimethoprim [738-70-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A	DDX51 MUC5B N4BP3 NFKB2 CLEC2D FGF5 OSBP2 DCLK1	1.02e-04	197	166	8	2307_UP
Drug	Thalidomide [50-35-1]; Up 200; 15.4uM; HL60; HG-U133A	MBOAT7 NACA ZNF202 FANCA THY1 CD70 DGCR8 FLRT1	1.06e-04	198	166	8	1411_UP
Drug	ST021200; Up 200; 10uM; MCF7; HT_HG-U133A	SMG5 KDM5D SLC1A7 CT62 CCDC88A CD6 THY1 BTBD7	1.06e-04	198	166	8	7488_UP
Drug	Nitrofurantoin [67-20-9]; Up 200; 16.8uM; MCF7; HT_HG-U133A	EMC1 JMJD4 KDM5D HOXA1 FANCA OSBP2 DGCR8 MYB	1.06e-04	198	166	8	4697_UP
Drug	Furosemide [54-31-9]; Up 200; 12uM; MCF7; HT_HG-U133A	TTLL5 ITGAX SLC1A7 RYR1 L3MBTL1 SCNN1A SORCS3 CD70	1.06e-04	198	166	8	3197_UP
Drug	Etodolac [41340-25-4]; Up 200; 14uM; MCF7; HT_HG-U133A	MARCHF8 PRR5 MUC5B N4BP3 TEP1 CCDC88A CD6 PATJ	1.06e-04	198	166	8	7006_UP
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A	KDM5B STON1 STXBP5L N4BP3 GUCY1B1 NFKB2 SCNN1A CACNA1I	1.06e-04	198	166	8	5477_UP
Drug	Fusaric acid [536-69-6]; Down 200; 22.4uM; PC3; HT_HG-U133A	DDX31 TTLL5 JMJD4 SMG5 PTGS2 BTBD7 OSBP2 PATJ	1.06e-04	198	166	8	3986_DN
Drug	Niacin [59-67-6]; Up 200; 32.4uM; MCF7; HT_HG-U133A	DDX51 PHC3 CD6 THY1 NFATC1 NFKB2 FGF5 DGCR8	1.06e-04	198	166	8	3381_UP
Drug	Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; PC3; HT_HG-U133A	STON1 ZNF202 MUC5B TEP1 ADCY1 NFATC3 FLCN DGCR8	1.06e-04	198	166	8	4592_DN
Drug	9-deoxy-9-methylene-16,16-dimethyl Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A	CRIM1 NLRX1 ZNF202 NPHP4 ARG2 CCDC88A BTBD7 PATJ	1.10e-04	199	166	8	7552_DN
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; HL60; HT_HG-U133A	AFF3 MAU2 RYR1 THY1 GUCY1B1 CACNA1I DGCR8 FAM149A	1.10e-04	199	166	8	2408_UP
Drug	Avermectin B1 [71751-41-2]; Up 200; 4.8uM; PC3; HT_HG-U133A	CCNJL RYR1 HIVEP3 L3MBTL1 TMEM132A FGF5 CD70 PATJ	1.10e-04	199	166	8	5864_UP
Drug	Remoxipride Hydrochloride [73220-03-8]; Down 200; 9.8uM; MCF7; HT_HG-U133A	EMC1 MBOAT7 PELI1 BTBD7 DGCR8 PATJ IQCE ALG13	1.10e-04	199	166	8	5443_DN
Drug	Amodiaquin dihydrochloride dihydrate [6398-98-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A	CCNJL TTLL5 AFF3 DDX51 N4BP3 ITGAX CACNA1I DGCR8	1.10e-04	199	166	8	3186_UP
Drug	Domperidone maleate; Up 200; 7.4uM; MCF7; HT_HG-U133A	CCNJL JMJD4 SLC1A7 CNPPD1 LRFN4 BTBD7 SCNN1A CD70	1.10e-04	199	166	8	2655_UP
Drug	AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A	TTLL5 HIVEP3 AAAS NFATC3 FGF5 AFF1 DGCR8 PATJ	1.10e-04	199	166	8	5949_DN
Drug	Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; PC3; HT_HG-U133A	TTLL5 TEX15 PTGS2 SLC1A7 L3MBTL1 AFF1 OSBP2 PATJ	1.10e-04	199	166	8	4228_DN
Drug	Sparteine (-) [90-39-1]; Up 200; 17uM; HL60; HT_HG-U133A	DDX31 SLC1A7 FANCA NFKB2 CD70 DGCR8 FLRT1 PALLD	1.14e-04	200	166	8	2134_UP
Disease	dyslexia (implicated_via_orthology)	DCLK2 DCLK1	3.03e-05	2	163	2	DOID:4428 (implicated_via_orthology)
Disease	mean reticulocyte volume	STON1 CRIM1 MARCHF8 NLRX1 AFF3 SERTAD2 MAU2 JMJD1C GFI1B PTPN1 FLCN AFF1 OSBP2 MYO16 MYB	3.97e-05	799	163	15	EFO_0010701
Disease	basophil percentage of granulocytes	JMJD1C RYR1 GFI1B AFF1 MYB	9.92e-05	83	163	5	EFO_0007995
Disease	syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology)	KDM5B KDM5D	1.81e-04	4	163	2	DOID:0060809 (implicated_via_orthology)
Disease	transmembrane protein 132A measurement	CD6 TMEM132A	1.81e-04	4	163	2	EFO_0802150
Disease	hypertension, pregnancy-induced	ZNF831 FGF5	3.00e-04	5	163	2	MONDO_0024664
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B PTGS2 OSBP2	4.41e-04	64	163	4	DOID:4947 (is_marker_for)
Disease	Precocious Puberty	PTGS2 LHB	6.25e-04	7	163	2	C0034013
Disease	Cryptogenic sexual precocity	PTGS2 LHB	6.25e-04	7	163	2	C0271527
Disease	Central Precocious Puberty	PTGS2 LHB	6.25e-04	7	163	2	C0342543
Disease	Testotoxicosis	PTGS2 LHB	8.31e-04	8	163	2	C1504412
Disease	idiopathic pulmonary fibrosis (is_implicated_in)	MUC5B PTGS2	1.06e-03	9	163	2	DOID:0050156 (is_implicated_in)
Disease	heparin-binding egf-like growth factor measurement	ZC3H12B JMJD1C	1.33e-03	10	163	2	EFO_0020438
Disease	X-11315 measurement	LIMD1 MROH6	1.61e-03	11	163	2	EFO_0021223
Disease	Proteinuria	MUC16 PTGS2 SCNN1A	1.74e-03	43	163	3	C0033687
Disease	pulse pressure measurement	MXRA5 CRIM1 NOX4 PCDHA2 HEATR5A CD46 ZNF831 HIVEP3 TBX18 AREL1 SENP1 CDC16 SORCS3 FGF5 PALLD GARRE1 NIN	1.86e-03	1392	163	17	EFO_0005763
Disease	Colorectal Carcinoma	FPGS CD46 PTGS2 SLC1A7 CNPPD1 HIVEP3 GFI1B NFATC1 PCDH11X FLCN DCLK1	1.88e-03	702	163	11	C0009402
Disease	esophagus adenocarcinoma (is_marker_for)	FOXA1 PTGS2	1.93e-03	12	163	2	DOID:4914 (is_marker_for)
Disease	B-Cell Lymphomas	PTGS2 PTPN1	1.93e-03	12	163	2	C0079731
Disease	response to radiation, hearing loss, response to antineoplastic agent	TTYH2 BBS2 ADCY1	2.11e-03	46	163	3	EFO_0004238, GO_0009314, GO_0097327
Disease	aortic measurement	NOX4 CD46 JMJD1C HIVEP3 TBX18 FGF5	2.79e-03	251	163	6	EFO_0020865
Disease	liver volume	MAU2 JMJD1C	3.04e-03	15	163	2	EFO_0600048
Disease	response to peritoneal dialysis, peritoneal solute transfer rate	SERTAD2 NFATC1	3.04e-03	15	163	2	EFO_0600089, EFO_0600090
Disease	mean corpuscular hemoglobin concentration	STON1 MARCHF8 POLR2A SERTAD2 SMG5 MAU2 GFI1B PTPN6 UBR5 SEC16A AFF1 CACNA1I MYO16 MYB	3.38e-03	1105	163	14	EFO_0004528
Disease	DiGeorge Syndrome	JMJD1C DGCR8	3.46e-03	16	163	2	C0012236
Disease	syndromic intellectual disability (implicated_via_orthology)	KDM5B KDM5D	3.46e-03	16	163	2	DOID:0050888 (implicated_via_orthology)
Disease	CONOTRUNCAL ANOMALY FACE SYNDROME	JMJD1C DGCR8	3.46e-03	16	163	2	C0795907
Disease	preeclampsia, hypertension, pregnancy-induced	ZNF831 FGF5	3.46e-03	16	163	2	EFO_0000668, MONDO_0024664
Disease	preeclampsia, parental genotype effect measurement	ZNF831 FGF5	3.46e-03	16	163	2	EFO_0000668, EFO_0005939
Disease	Shprintzen syndrome	JMJD1C DGCR8	3.46e-03	16	163	2	C0220704
Disease	intelligence, self reported educational attainment	AFF3 JMJD1C SORCS3 CACNA1I	4.10e-03	117	163	4	EFO_0004337, EFO_0004784
Disease	Hypertensive disease	NOX4 PTGS2 LHB PTPN1 SCNN1A	4.17e-03	190	163	5	C0020538
Disease	adverse effect, response to xenobiotic stimulus	STON1 SCNN1A VWA3B	4.29e-03	59	163	3	EFO_0009658, GO_0009410
Disease	response to antipsychotic drug	STXBP5L ZNF202 ZNF831	4.50e-03	60	163	3	GO_0097332
Disease	basophil measurement	PELI1 GFI1B AFF1	4.50e-03	60	163	3	EFO_0803539
Disease	alcohol use disorder (implicated_via_orthology)	KDM5B KDM5D ADCY1 JMJD1C RYR1	4.65e-03	195	163	5	DOID:1574 (implicated_via_orthology)
Disease	anorectal malformation	MUC5B LTB4R2	4.88e-03	19	163	2	MONDO_0019938
Disease	triglycerides to total lipids in very large HDL percentage	JMJD1C AFF1 FLRT1	4.93e-03	62	163	3	EFO_0022339
Disease	methadone dose measurement	NHLRC1 TEX15 PATJ	4.93e-03	62	163	3	EFO_0007907
Disease	CCL2 measurement	LIMD1 SERTAD2 HIVEP3 FAM149A	5.33e-03	126	163	4	EFO_0004749
Disease	Adenocarcinoma of prostate	FOXA1 FANCA	5.40e-03	20	163	2	C0007112
Disease	acylcarnitine measurement	MARCHF8 SLC1A7 NFATC1 MYO16	5.48e-03	127	163	4	EFO_0005059

Protein segments in the cluster

Peptide	Gene	Start	Entry
TSALPHLLICPGFHT	nan	591	A8MVM7
HSSSGHCVQNFPPSL	AFF3	206	P51826
PSSGCAQVLSHPGHT	AAAS	231	Q9NRG9
TATHPTCTLLFPSCH	ALG13	176	Q9NP73
SLAIGTISGHARHCP	ARG2	121	P78540
GNTPLHLAACTNHVP	ANKRD54	176	Q6NXT1
AHCNLHLPGSSNSPA	CCNJL	111	Q8IV13
GTVFSSPCLNLIPHH	AASDH	896	Q4L235
TPIHLASACGHTAVL	ANKRD52	756	Q8NB46
GSETHLALCPIVQHP	CD163L1	866	Q9NR16
CSGHSPRTARHAPAV	DGCR8	91	Q8WYQ5
SRHHPTTLAVGICSP	CD70	121	P32970
TPGRLIDHLHNCPSF	DDX27	346	Q96GQ7
ASHPLHPPLCISTGA	ARRDC1	366	Q8N5I2
FSGPHLQTLCHFVLP	ABHD15	101	Q6UXT9
PLHCPNGSAILHTYT	MUC5B	5716	Q9HC84
LHPSLLGEPHCFQVT	RASAL3	251	Q86YV0
HAPSLHGSTELLPLS	RABEP2	186	Q9H5N1
SPSQLLACGPTVHHE	ITGAX	101	P20702
SHPPACLASSSALHR	IQCE	366	Q6IPM2
QRPLHTPIIVHCSSG	PTPN23	1381	Q9H3S7
TNGHVTCSLTPHVPF	PCDHA2	381	Q9Y5H9
ELHASHIPTANPGHC	CD6	531	P30203
PLRTFTCLHVPGTHS	CACNA1F	1871	O60840
TCLHVPGTHSDPSHG	CACNA1F	1876	O60840
SLHLEPPETGVSHLC	FAM47C	461	Q5HY64
AICTHHLNPQSPGLD	MUC16	13081	Q8WXI7
PTCVTPHGTVLHQTL	FAM189A1	221	O60320
SGSLSPEHGPVVVHC	PTPN1	201	P18031
LSFLHACSPPIIHGN	NRBP2	161	Q9NSY0
PGYTHLASVSHPQSC	LRP10	206	Q7Z4F1
IPPLATHTICDRNHT	CD46	71	P15529
PCGDHPLNHRQLSLS	LIMD1	221	Q9UGP4
HPSHPQLFSIVRQAC	FLCN	111	Q8NFG4
HSHRGATATLPCVLG	HAPLN2	46	Q9GZV7
VHRPPLSACGHSSNI	FAM149A	346	A5PLN7
PHTLVSSGGSLLHLC	MYO16	86	Q9Y6X6
FKTTHAPPGDTLVHC	KCNH7	761	Q9NS40
LQPLPSSHLVHPSCH	GAB3	226	Q8WWW8
STHLLIHSDTRPYPC	GFI1B	236	Q5VTD9
PTSHTACPLPGTCHI	KRT37	71	O76014
HPLTCDHPQLSGLLF	LHB	126	P01229
RTCLNPGTHHPALTP	JMJD1C	746	Q15652
SHSSIKGQHPPCGLS	ESPN	386	B1AK53
VSLGSSPPCRHHVPS	LMLN	56	Q96KR4
FHGQCVSVPHLLTSP	KDM5D	1196	Q9BY66
RVNGLPSPTHSAHCS	DCLK1	26	O15075
GNGLIPSPAHSAHCS	DCLK2	41	Q8N568
LCLAFHPTQPSHVAG	DYNC2I2	221	Q96EX3
LHFLPHASSSAQSPC	CCDC88A	221	Q3V6T2
GVHSLLCSLPTHLLA	L3MBTL1	816	Q9Y468
ESLPHLLFSPHSGLS	OR2W5P	236	A6NFC9
GLVHLTAHSSLVCPL	MSTO1	286	Q9BUK6
LIHCDPSTSHVSGRP	FAM214A	381	Q32MH5
AGVSHLCLEPPNTHR	FAM47B	326	Q8NA70
AHSTLPAPCHNLQTS	NFATC1	61	O95644
TQGFTPDRLPAHSCH	PLK5	66	Q496M5
LPSTLSGHRVCQAHG	PDZD3	71	Q86UT5
SPLITPCHCTGSLHF	MARCHF8	91	Q5T0T0
CGPHTLHSLVTILGT	MBOAT7	46	Q96N66
VLALSHTANPCCSHP	PTGS2	11	P35354
TVSGLPEPCIHHARS	GUCY1B1	481	Q02153
LHSPFSTGRSCIPLH	KDM5B	1326	Q9UGL1
SCLGEHHSTPSLPAD	MYB	346	P10242
LSHRGPPHSHASCAV	MROH6	291	A6NGR9
TSTGLTCHAHLPPLF	AP5B1	746	Q2VPB7
SPLHASHQEACRSPA	HOXA1	181	P49639
LVCATLHFLHAPTPA	NLRX1	376	Q86UT6
CHSPPVTQTIALCHS	PCDH11X	1196	Q9BZA7
ALCHSPPPIQVSALH	PCDH11X	1206	Q9BZA7
CAPGSLLHHASPTQT	DDX31	91	Q9H8H2
GTLPHCAVLHTLASL	MROH1	136	Q8NDA8
PDPAILFHTCHSVGQ	MROH1	1026	Q8NDA8
SSPGLTRHINKCHPS	INSM2	536	Q96T92
GLRSLCEQVSHHPPS	OSBP2	616	Q969R2
QTLSHRPCHLSQGPA	POU2F3	56	Q9UKI9
HCSPIQSHPSPLTVS	PHC3	371	Q8NDX5
QHCLARPTSQLPHGS	NPHP4	516	O75161
LHCPSVSALENHPFT	NOX4	341	Q9NPH5
HCSSPATRFGHSQTP	PALLD	836	Q8WX93
GCSPRVKPQHISTHF	FGF5	201	P12034
ALASVPASHPAHGLA	FOXA1	366	P55317
RTALPTLPCESTHHA	ADCY1	716	Q08828
STHHALLCCLVGTLP	ADCY1	726	Q08828
DPFHASCLPVHIGTL	CDC16	261	Q13042
SPTCHACLHPNRTVP	CNPPD1	346	Q9BV87
PGARVTFNCSTPHQH	IGSF1	791	Q8N6C5
VPPTHAEVHQSLGRC	HEATR5A	986	Q86XA9
LTVPPSHTEVHQCLG	HEATR5B	986	Q9P2D3
HPSIHNLSSSICIPI	BBS2	431	Q9BXC9
AEASELTLGPTCPHH	SLC1A7	516	O00341
PVGLTHHYVPCSLSS	DDX51	476	Q8N8A6
HPHSGLCLSAYRTPE	GALNT4	541	Q8N4A0
PCSVVGHVFRTKSPH	GALNT6	401	Q8NCL4
CQLLRHQGPSLSAPH	FANCA	766	O15360
CPPHLARSLQSHDGV	AXDND1	146	Q5T1B0
LGSRHCQTLHGPASP	CACNA1I	501	Q9P0X4
TAPLGSLTAAGSCHH	GARRE1	51	O15063
VTSPALCDTHLHPRN	JMJD4	276	Q9H9V9
PPILSGTCLTVDGHH	CRIM1	601	Q9NZV1
DSTPALPCLHQPTHL	AKNA	676	Q7Z591
IAAPTHSTLPTAHTC	AREL1	776	O15033
SCLPSPTHEAASKGH	ASB5	166	Q8WWX0
PCNHSLFHSRTAPKA	BTBD7	796	Q9P203
GSSCPASHCRDLLPH	HOXC13	61	P31276
GSASLLLAPHPPHTC	FPGS	496	Q05932
LLAPHPPHTCSASSL	FPGS	501	Q05932
CHSLRSFHNAPPLSA	KRTAP27-1	6	Q3LI81
RTTAHFPHPPQCTLL	EMC1	576	Q8N766
PYGQLSTSCHSHLVP	DPEP3	426	Q9H4B8
LSRNHLSSIPSGLPH	FLRT1	156	Q9NZU1
FPFLLHTCSHPLSHP	CT62	116	P0C5K7
TSPCPLHLGASVLHT	DUOXA1	231	Q1HG43
ASTLASSPPSHFCPH	SCNN1A	606	P37088
PDHSFPVSSHCLRAA	MAU2	446	Q9Y6X3
PHLVGPSRCLSHTDF	RYR1	836	P21817
NLHLASLPPGHTLFS	POLR3E	586	Q9NVU0
HHNLRLPCSSDSPAS	C9orf85	126	Q96MD7
PCASGLLCQPHSHSL	DKK3	266	Q9UBP4
AAPSAPGALTCHHTF	NHLRC1	106	Q6VVB1
SSLHSPHCKRQPSLG	PRR14L	1901	Q5THK1
PHCKRQPSLGTTSSH	PRR14L	1906	Q5THK1
CHSPPPIQVSALHHS	PCDH11Y	1201	Q9BZA8
QIPLPHGTHTFHAAC	PELI1	381	Q96FA3
HCLPLHGKISAESPT	SYTL4	476	Q96C24
AGDAAVLPCTFTHPH	SIGLEC15	56	Q6ZMC9
TNPHTSASHRPCVNG	SMG5	596	Q9UPR3
SLPCARLHATHPAGT	TMEM132A	156	Q24JP5
CHPSPVHAAAHLSLE	LTB4R2	171	Q9NPC1
SLPGHLCSPTSHSSF	NIN	2066	Q8N4C6
GSPVHCLLPFCSLHL	SORCS3	536	Q9UPU3
GLHSSEGPFTHSCIL	PRR5	216	P85299
HSPHCTVSIVLQAPR	PKDREJ	1071	Q9NTG1
PTTHFPLHLSRCLSS	SENP1	211	Q9P0U3
CLPASHAVSVIHPSS	WHAMM	576	Q8TF30
ICKTVRHGFPHQPTA	STXBP5L	61	Q9Y2K9
LHAKSCGPPDSQHLT	AFF1	146	P51825
ASPESLHYHLCSAPR	CHST14	331	Q8NCH0
LPANPGCLHSKEHSI	CLEC2D	16	Q9UHP7
SGPGSHLLSTHPILC	NDUFV1-DT	51	Q8NBR9
DHGHPLLPASASSSL	SEMA6B	736	Q9H3T3
SPLNSHCAHREPISS	SHF	51	Q7M4L6
LAQHLRTHCPPTQSL	ZNF414	126	Q96IQ9
PLCLATCLDHHFPTG	ST6GALNAC4	31	Q9H4F1
TCLDHHFPTGSRPTV	ST6GALNAC4	36	Q9H4F1
LSCSLLSHQRSHLGP	ZNF48	286	Q96MX3
TSIPAHSGPISHCAA	TEP1	2181	Q99973
LLVCQTHTLLGHSGP	TEP1	2226	Q99973
ASLTRPLHHQASACP	RNF111	651	Q6ZNA4
HTHARDSSQGPCEPL	SEC16A	96	O15027
TRPTCLSHALLPSDH	STON1	126	Q9Y6Q2
LSHALLPSDHSCTHP	STON1	131	Q9Y6Q2
AFSHLASPSSHPCDL	SERTAD2	106	Q14140
PHTTCLHAACGPVRA	TMEM250	16	H0YL14
AHSSCHPSFAPVITG	PATJ	1636	Q8NI35
GVPATHPHLLSGSSC	TBX18	381	O95935
HPHLLSGSSCSSPAF	TBX18	386	O95935
AAHSPPRGQLHSFCS	TTYH2	441	Q9BSA4
IPGHINCIRTHSTHP	POLR2A	596	P24928
AACTISTPHHPFRGS	HIVEP3	546	Q5T1R4
TYTCALHHSGHSPPI	THY1	101	P04216
CLPHHGLPSHSSVLS	NFATC3	61	Q12968
LGHSLSPRQSPCHSP	NFATC3	231	Q12968
VIPHSSLLDPSHCTQ	PKHD1L1	2811	Q86WI1
LHAQHPSTGTRSSCP	ZC3H12B	661	Q5HYM0
ESLPHAGPIIVHCSA	PTPN6	441	P29350
LASAHQCHPLPRTLS	UCKL1	311	Q9NWZ5
HCSPTRHPGSRIVLS	UCN2	61	Q96RP3
ISSHGSCQGTHPEPR	VWA3B	1231	Q502W6
SCQGTHPEPRTAHLH	VWA3B	1236	Q502W6
GVNHTPILPAHSETC	TEX15	1571	Q9BXT5
STGPAGHCPHLVESV	THSD7B	521	Q9C0I4
PHAPCSPLHSLSEHS	ZNF831	356	Q5JPB2
SLTAHHPDPGTLEQC	TMEM213	36	A2RRL7
TTPVHPLLGRHHDCS	ZNF202	386	O95125
FSHPAIHNLIQSCPG	TBRG1	296	Q3YBR2
SDLSPGPCHHSSLSQ	TTLL5	906	Q6EMB2
GPCHHSSLSQIPSAI	TTLL5	911	Q6EMB2
NPSLHHPRATFLGLT	UBR5	406	O95071
SAHCSLHLPGSSDSP	ZMAT1	16	Q5H9K5
HFSTLPASPLCHALQ	LRFN4	496	Q6PJG9
NISLPPGLSIHIHCT	MXRA5	2056	Q9NR99
PGLSIHIHCTAKAAP	MXRA5	2061	Q9NR99
FPISLGSHLAPLHQS	NACA	301	E9PAV3
NGSLHTLACHPPLSP	N4BP3	146	O15049
PPRAHAHSLVGKQCS	NFKB2	101	Q00653